Aristo Bio-Tech and Lifescience (NSE:ARISTO) Equity-to-Asset : 0.27 (As of Mar. 2025)

Aristo Bio-Tech and Lifescience Equity-to-Asset Chart

Aristo Bio-Tech and Lifescience Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24	Mar25
Equity-to-Asset	Get a 7-Day Free Trial				0.30	0.25	0.26	0.17	0.27

Competitive Comparison of Aristo Bio-Tech and Lifescience's Equity-to-Asset

For the Agricultural Inputs subindustry, Aristo Bio-Tech and Lifescience's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aristo Bio-Tech and Lifescience's Equity-to-Asset Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Aristo Bio-Tech and Lifescience's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Aristo Bio-Tech and Lifescience's Equity-to-Asset falls into.

Aristo Bio-Tech and Lifescience Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Aristo Bio-Tech and Lifescience's Equity to Asset Ratio for the fiscal year that ended in Mar. 2025 is calculated as

Aristo Bio-Tech and Lifescience's Equity to Asset Ratio for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aristo Bio-Tech and Lifescience  (NSE:ARISTO) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Aristo Bio-Tech and Lifescience Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Aristo Bio-Tech and Lifescience's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Aristo Bio-Tech and Lifescience Business Description